Appeals Court Refuses Merck's Petition for Rehearing in Fosamax Case

home   >   MSN news

A federal appeals court has rejected Merck's request to reconsider a January ruling that struck down the company's patent on blockbuster osteoporosis treatment Fosamax - a decision that opened the drug to generic competition a decade early.

- link to Appeals Court Refuses Merck's Petition for Rehearing in Fosamax Case -
Last update: 05/26/2005

Recommended Reading

    Advair Diskus. : An article from: Family Practice News
    Celebrex - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Celecoxib Approved for Familial Adenomatous Polyposis.(Brief Article)(Statistical Data Included) : An article from: Family Practice News
    Capturing Epogen[R] Overfill. : An article from: Nephrology Nursing Journal
    Infliximab Cut Psoriasis Severity Score by 75%. : An article from: Internal Medicine News
    Pain Management; Key Q&A. : An article from: NWHRC Health Center - Pain Management
    Anti-TNF Drugs' link to Infections Concerns FDA.(Brief Article) : An article from: Family Practice News
    Como Se Llama La Obra? - Chistes En Actos / Falto El Profe: Chistes Con Actos